Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...
Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership in progressive pulmonary fibrosis (PPF). The ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results